Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells. - Wikidata - wikimedia - TriplyDB

Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells.

Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells.

http://www.wikidata.org/entity/Q33686615

about

Epigenetics Offer New Horizons for Colorectal Cancer Prevention Epigenetic regulation by histone demethylases in hypoxia New developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in glioma The role of histone demethylases in cancer therapy The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1 The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.The hypoxia-inducible epigenetic regulators Jmjd1a and G9a provide a mechanistic link between angiogenesis and tumor growth.Small-molecular modulators of cancer-associated epigenetic mechanisms.STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers Histone Demethylases in Colon Cancer.Ephrin-A1 is up-regulated by hypoxia in cancer cells and promotes angiogenesis of HUVECs through a coordinated cross-talk with eNOS.Mitochondrial ferritin, a new target for inhibiting neuronal tumor cell proliferation.Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential.Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.The KDM3A-KLF2-IRF4 axis maintains myeloma cell survival.Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription.PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells.Jumonji domain-containing protein 1A promotes cell growth and progression via transactivation of c-Myc expression and predicts a poor prognosis in cervical cancer.Glioma stem cell maintenance: the role of the microenvironment.Roles of histone methyl-modifying enzymes in development and progression of cancer.Histone lysine demethylases as targets for anticancer therapy.The roles of Jumonji-type oxygenases in human disease.The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene.Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.KDM3A promotes inhibitory cytokines secretion by participating in TLR4 regulation of Foxp3 transcription in lung adenocarcinoma cells.KDM3A coordinates actin dynamics with intraflagellar transport to regulate cilia stability.JMJD1A promotes tumorigenesis and forms a feedback loop with EZH2/let-7c in NSCLC cells.Histone Modifications and Cancer.Control of histone H3 lysine 9 (H3K9) methylation state via cooperative two-step demethylation by Jumonji domain containing 1A (JMJD1A) homodimer.Writing, erasing and reading histone lysine methylations.A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resection.Regional differences in prostaglandin E₂ metabolism in human colorectal cancer liver metastases.KDM3A inhibition attenuates high concentration insulin‑induced vascular smooth muscle cell injury by suppressing MAPK/NF‑κB pathways.Cation-π interactions in CREBBP bromodomain inhibition: an electrostatic model for small-molecule binding affinity and selectivity.The potential of KDM3A as a therapeutic target in Ewing Sarcoma and other cancers.Dioxygen Binding in the Active Site of Histone Demethylase JMJD2A and the Role of the Protein Environment.Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB.JMJD1A, H3K9me1, H3K9me2 and ADM expression as prognostic markers in oral and oropharyngeal squamous cell carcinoma.A potential common role of the Jumonji C domain-containing 1A histone demethylase and chromatin remodeler ATRX in promoting colon cancer

P2860

Q22252606-F8F1A097-111A-48BD-9079-58C027B7D2B9 Q26825704-98A05760-1D1B-4381-852C-D74C8F767297 Q26863394-BF24B09C-F64E-4EDF-AA74-C190CC7ED3BA Q26864687-72332CBA-34B2-4774-B362-AB6B8028A179 Q33688385-9186E8C2-4B68-4FCE-BD23-B5FBED8E9151 Q33728316-4EDB6214-A8C2-403B-9A99-F758FC54358D Q34298049-A77DF417-F48C-4405-B347-876A7A9C18EA Q34628002-0E6C7EE7-DA83-4B00-89DE-EC79FA9872AD Q34796500-4040E323-5727-4EE4-9126-BB00C1D86037 Q34822197-10706777-579E-44AD-B616-58B700685C1D Q34990038-B1201241-3032-4AA4-922A-06755BD3D20B Q35069781-5417C6F8-002E-454E-971C-58022CF0EB05 Q35589633-E5B54578-98AA-4F11-B4DB-1D58AB3B89E2 Q36261640-2F4F56FB-E3B6-4879-A125-D495832066F8 Q36506849-767ABAA7-69B6-494A-827A-4AAF386A18CC Q37157064-A644B4E5-4651-4806-834E-9AFE3AAAEC65 Q37214337-E07A85FE-8105-47FA-97C4-6D087FE372F4 Q37709105-635F3FA8-2C8A-4371-BD87-BDC3F352121E Q37914244-C5B720DC-1392-4ECD-93AC-F2844273E729 Q38096423-504C361F-D853-405C-977E-C44201397EEC Q38162717-FB1450F6-CE9D-44ED-B778-DB196090B630 Q38192028-46F51543-036C-47A3-8F15-D63D6901CD03 Q38330908-32F55EDB-38E9-4298-A08D-29DE4BCDDF49 Q38686609-B458F27B-F1F3-47FB-BBF3-2F9D2411A9E4 Q38703026-19743FBD-0580-4762-806F-0764F9D357AA Q38714439-3C8BD87C-5F78-4B3B-B300-5A8F1417FF1D Q38788734-33373F54-5E6D-4DBB-876D-EE715A5B175C Q38796064-C449F125-9AEA-4508-BF8B-319178F8E8C1 Q39064738-7E089D70-1AD7-4770-A737-581A129BF612 Q39268171-3E0AB691-C2FF-4127-9012-EDF33EB57568 Q39430077-A53CA5E8-7950-4BAB-8648-95C968AF4F14 Q39440705-1047E668-37EF-4567-A8FD-FD898DD3B075 Q41081492-1C34CCFD-8DA4-4BF2-AB2B-5A317C2F5E5C Q47246628-A873D04F-43FD-4904-AB59-255DF6C5E76B Q48245176-BBB47E6D-3662-4ED3-966D-B4C3085F33A3 Q49426157-454EC930-522A-4F7E-9201-A9389275B3FD Q51641598-94050861-B91C-4803-B3D7-998452B1E407 Q54858561-D9FE9D65-D009-48A8-BB74-CA0FDBC9863E Q55350714-75136AA6-733E-4046-B7F7-F8A5257B0789 Q58572320-282D566D-C45E-4747-BDEF-DAB0B7BD0E4A

P2860

Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells.

http://www.wikidata.org/entity/Q33686615

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Jumonji domain containing 1A i ...... tion from hypoxic tumor cells.

@ast

Jumonji domain containing 1A i ...... tion from hypoxic tumor cells.

@en

type

label

Jumonji domain containing 1A i ...... tion from hypoxic tumor cells.

@ast

Jumonji domain containing 1A i ...... tion from hypoxic tumor cells.

@en

prefLabel

Jumonji domain containing 1A i ...... tion from hypoxic tumor cells.

@ast

Jumonji domain containing 1A i ...... tion from hypoxic tumor cells.

@en

P1433

Q33686615-606B9423-E2D6-4124-B8B4-5B2A053933E5

P1476

Q33686615-DDA7935E-1D6C-4BD4-A650-26820C4B9589

P2093

Q33686615-2752A170-E1CF-4E24-91A4-B18EAF8D7D9B

Q33686615-46BCA369-94C2-4ABD-A2F6-9A2816FADB8B

Q33686615-5E99733F-9B5A-4F69-B135-580A4A6DD5E9

Q33686615-95E8C795-A3BC-463D-A3EA-B7994E7BC778

Q33686615-AD7FDFBF-A357-4B85-948B-C8637403E4B5

Q33686615-DA89061C-B622-4DE7-9EF2-DAA4041C8229

Q33686615-DBE53010-A1F3-4CAF-85D1-2F3BD089E0EB

Q33686615-E61B5278-443D-4348-B73F-99BB324C4FB8

Q33686615-E6E703AF-7C7C-49AB-9A6C-DBC058A17FD0

P304

Q33686615-87C4B4E3-E72F-4A11-B26E-D2687FD0C9C0

P31

Q33686615-79243AAB-AA69-48EE-BFA5-A4240E2E1866

P356

Q33686615-1E332FB1-5ECE-40CF-A573-C6697DD7E06F

P407

Q33686615-8A3E743D-132F-48FD-B080-B18545FBB72F

P433

Q33686615-DB8AFDBB-BB1C-42F4-B69D-618614816BF6

P478

Q33686615-2C52561E-5EAC-461E-B411-BE39B410F82E

P50

Q33686615-6541813E-56B8-426E-B969-19F2507BF6FB

Q33686615-8AF95B32-2B91-413B-8237-C00B83CAA433

P577

Q33686615-75D33404-6181-400D-8408-3F944F3E4C79

P698

Q33686615-5F03C287-113E-4980-8F6D-63F6135922C0

P921

Q33686615-A6EFDEB3-BB81-439A-A55D-ABCDCA992943

Q33686615-F7BA2AEA-C771-4A09-AF8C-290B1B3D986E

P356

1078-0432.CCR-10-0407

P1433

Clinical Cancer Research

P1476

Jumonji domain containing 1A i ...... tion from hypoxic tumor cells.

@en

P2093

Hideyuki Hemmi

http://www.w3.org/2001/XMLSchema#string

Hirofumi Yamamoto

http://www.w3.org/2001/XMLSchema#string

Ichiro Takemasa

http://www.w3.org/2001/XMLSchema#string

Koshi Mimori

http://www.w3.org/2001/XMLSchema#string

Mamoru Uemura

http://www.w3.org/2001/XMLSchema#string

Masataka Ikeda

http://www.w3.org/2001/XMLSchema#string

Mitsugu Sekimoto

http://www.w3.org/2001/XMLSchema#string

Nariaki Matsuura

http://www.w3.org/2001/XMLSchema#string

Tsunekazu Mizushima

http://www.w3.org/2001/XMLSchema#string

P304

4636-4646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-10-0407

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20823141

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer